Introduction: Hepatocyte growth factor and met receptor, from discovery to therapeutic implications

Current Signal Transduction Therapy

Volumn 6, Issue 2, 2011, Pages 143-145

  Nakamura, Toshikazu ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

HGF; Met; NK4; Simple duplication

Indexed keywords

ANGIOGENESIS INHIBITOR; NK4; RECOMBINANT SCATTER FACTOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ACUTE KIDNEY FAILURE; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER INVASION; DRUG ACTIVITY; DRUG MECHANISM; HEART INFARCTION; LIVER REGENERATION; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE REPAIR;

EID: 79957941380     PISSN: 15743624     EISSN: 15743624     Source Type: Journal    
DOI: 10.2174/157436211795659937     Document Type: Article

References (24)

1. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-9. (Pubitemid 14073577)
2. Russel WE, McGowan JA, Bucher NL. Partial characterization of hepatocyte growth factor from rat platelets. J Cell Physiol 1984; 119: 183-92. (Pubitemid 14112405)
3. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 1986; 83: 6489-93. (Pubitemid 17174760)
4. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. Purification and subunit structure of hepatocyte a growth factor from rat platelets. FEBS Lett 1987; 224: 311-316.
5. Gohda E, Tsubouchi H, Nakayama H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988; 81: 414-9. (Pubitemid 18075233)
6. Zarnegar R, Michalopoulos G. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res 1989; 49: 3314-20. (Pubitemid 19162144)
7. Asami O, Ihara I, Shimidzu N, et al. Purification and characterization of hepatocyte growth factor from injured liver of carbon tetrachloride-treated rats. J Biochem 1991; 109: 8-13.
8. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989: 342: 440-3. (Pubitemid 19277521)
9. Miyazawa K, Tsubouchi H, Naka D, et al. Molecular cloning and sequence analysis of cDNA for human hepatocye growth factor. Biochem Biophys Res Commun1989; 63: 967-73. (Pubitemid 19236944)
10. Tashiro K, Hagiya M, Nishizawa T, et al. Deduced primary structure of rat hepatocyte growth factor and expression of mRNA in rat tissues. Proc Natl Acad Sci USA 1990; 87: 3200-04.
11. Birchmeier C, Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1988; 8: 404-10.
12. van der Voot R, Taher TE, Derksen PW, Spaargaren M, van der Neut R, Pals ST. The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation. Adv Cancer Res 2000; 79: 39-90. (Pubitemid 30228120)
13. Higuchi O, Nakamura T. Identification and change in the receptor for hapatocyte growth factor in rat liver after partial hepatoectomy or induced hepatitis. Biochem Biophys Res Commun 1991; 176: 599-607.
14. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor as the c-met proto-oncogene product. Science 1991; 251: 802-4. (Pubitemid 21926175)
15. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915-25. (Pubitemid 37493640)
16. Mizuno S, Nakamura T. Hepatocyte Growth factor: a regenerative drug for acute hepatitis and liver cirrhosis. Regen Med 2007; 2: 161-70. (Pubitemid 46831077)
17. Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life science and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci 2010; 86: 588-610.
18. Hashigasako A, Machide M, Nakamura T, Matsumoto K, Nakamura T. Bi-directional regulation of Ser-985 phosphorylation of cmet via protein kinase C and protein phosphatase 2A involes c-Met activation and cellular responsiveness to hepatocyte growth factor. J Biol Chem 2004; 279: 26445-52. (Pubitemid 38798797)
19. Kadoyama K, Funakoshi H, Nakamura T, Sakaeda T. Therapeutic potential of hepatocyte growth factor for treating neurological diseases. Current Drug Therapy 2010; in press.
20. Matsumoto K, Nakamura T. Hepatocyte growth factor and Met system as a mediator of tumor-stromal interactions. Int J Cancer 2006; 119: 477-83 (Pubitemid 43955698)
21. Matsumoto K, Nakamura T. NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics. Cancer Sci 2003; 94: 321-7. (Pubitemid 36626362)
22. Matsumoto K, Nakamura T. NK4 gene therapy, targeting HGF-Met and angiogenesis. Front Biosci 2008; 13: 1943-51. (Pubitemid 351599746)
23. Jiang WG, Martin TA, Parr C, Davies G, Matsumoto K, Nakamura T. Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit Rev Oncol Hematol 2005; 53: 35-69. (Pubitemid 39656109)
24. Comoglio PM, Giordano S, Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 2008; 7: 504-16. (Pubitemid 351767118)